ClinVar Miner

Submissions for variant NM_000501.4(ELN):c.643+1_643+2delinsAG

dbSNP: rs1554672602
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000560237 SCV000622213 pathogenic Supravalvar aortic stenosis 2017-08-07 criteria provided, single submitter clinical testing Family studies have indicated that this variant was not present in the parents of an individual with ELN-related disease, which suggests that it was de novo in that affected individual (Invitae). For these reasons, this variant has been classified as Pathogenic. Donor and acceptor splice site variants typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in ELN are known to be pathogenic (PMID: 11175284). This variant has not been reported in the literature in individuals with ELN-related disease. This variant is not present in population databases (ExAC no frequency). This sequence change affects a donor splice site in intron 12 of the ELN gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.